Podlewska, Aleksandra M.
Batzu, Lucia
Soukup, Tayana
Sevdalis, Nick
Bakolis, Ioannis
Derbyshire-Fox, Fleur
Hartley, Alison
Healey, Andy
Woods, Anthony
Crane, Nikki
Pariante, Carmine
Ray Chaudhuri, K
Funding for this research was provided by:
Wellcome Trust (RE16059, RE16059, RE16059, RE16059, RE16059, RE16059, RE16059, RE16059, RE16059, RE16059, RE16059)
Article History
Received: 8 November 2023
Accepted: 6 December 2023
First Online: 17 January 2024
Declarations
:
: The study has been approved by the Health Research Authority in the United Kingdom (Research Ethics Committee Hub Wales 7, 20/WA/0261) and will be conducted in compliance with Declaration of Helsinki and Good Clinical Practice guidelines. The study has been also included in the National Institute of Health Research Portfolio (CPMS ID: 46594) and registered on the global registry of clinical trials (ClinicalTrials.gov Identifier: NCT04719468). Informed consent will be signed at the screening visit prior to any study-related activities being performed. If all inclusion criteria are satisfied and no exclusion criteria are met, study team will conduct all baseline measures.
: Not applicable.
: The authors declare no competing interests.